Adjuvant diagnosis of tuberculosis in hemodialysis patients using fourth generation interferon γ releasing assay

Dialysis patients have a 10–25 times higher risk of reactivation of tuberculosis (TB). In this study, we investigated the diagnostic ability of QuantiFERON (QFT)‐plus for TB in hemodialysis patients. QFT‐plus, an interferon gamma release assay, is characterized by its use of CD4 and CD8 T cell signals.

[1]  Chong-Jen Yu,et al.  CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysis , 2020, Scientific Reports.

[2]  O. Djurdjev,et al.  Latent Tuberculosis Therapy Outcomes in Dialysis Patients: A Retrospective Cohort. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  M. Pai,et al.  Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence? , 2020, Journal of Clinical Microbiology.

[4]  Y. Hiroi,et al.  SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine. , 2020, Global health & medicine.

[5]  P. Rancoita,et al.  First evaluation of QuantiFERON-TB Gold Plus performance in contact screening , 2016, European Respiratory Journal.

[6]  N. Tangri,et al.  The Diagnostic Accuracy of Tests for Latent Tuberculosis Infection in Hemodialysis Patients: A Systematic Review and Meta-Analysis , 2015, Transplantation.

[7]  Chong-Jen Yu,et al.  Comparison of the Prevalence of Latent Tuberculosis Infection among Non-Dialysis Patients with Severe Chronic Kidney Disease, Patients Receiving Dialysis, and the Dialysis-Unit Staff: A Cross-Sectional Study , 2015, PloS one.

[8]  S. Mahmoudi,et al.  Diagnosis of Latent Tuberculosis Infection Among Immunodeficient Individuals: Review of Concordance Between Interferon-γ Release Assays and the Tuberculin Skin Test , 2014, British journal of biomedical science.

[9]  M. Pai,et al.  Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection , 2014, Clinical Microbiology Reviews.

[10]  G. Marks,et al.  Risk of Tuberculosis in Dialysis Patients: A Nationwide Cohort Study , 2011, PloS one.

[11]  T. Hoshino,et al.  The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  A. Webster,et al.  Tests for latent tuberculosis in people with ESRD: a systematic review. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.